Enzo Biochem Files 8-K on Financials
| Field | Detail |
|---|---|
| Company | Enzo Biochem Inc |
| Form Type | 8-K |
| Filed Date | Mar 18, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, filing
TL;DR
Enzo Biochem dropped an 8-K on March 17th detailing financials - check it for the real scoop.
AI Summary
Enzo Biochem, Inc. filed an 8-K on March 18, 2025, reporting on its results of operations and financial condition as of March 17, 2025. The filing includes financial statements and exhibits, but does not detail specific financial figures or operational outcomes within the provided text.
Why It Matters
This filing provides an update on Enzo Biochem's financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting financial condition and results of operations, without immediate indication of significant negative events.
Key Players & Entities
- ENZO BIOCHEM, INC. (company) — Registrant
- March 17, 2025 (date) — Date of earliest event reported
- March 18, 2025 (date) — Date of report
- New York (location) — State of incorporation
- 631-755-5500 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Enzo Biochem, Inc.?
The primary purpose of this 8-K filing is to report on Enzo Biochem, Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
On what date is the earliest event reported in this filing?
The earliest event reported in this filing is dated March 17, 2025.
What is the filing date of this Current Report?
This Current Report was filed on March 18, 2025.
What is Enzo Biochem, Inc.'s state of incorporation?
Enzo Biochem, Inc. is incorporated in New York.
What is the principal executive office address for Enzo Biochem, Inc.?
The address of the principal executive offices for Enzo Biochem, Inc. is 21 Executive Blvd., Farmingdale, New York 11735.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 18, 2025 regarding ENZO BIOCHEM INC.